Did Vaccines Save Us?
What the Mortality Data Actually Shows

Water & Sewage

Chlorination and water treatment began in the early 1900s. Separating sewage from drinking water eliminated cholera and typhoid virtually on contact. The CDC credits this as the primary factor in waterborne disease deaths — not vaccination. By 1908, 40 of 45 states had health departments coordinating water safety.

Housing & Reduced Crowding

TB, scarlet fever, and respiratory diseases declined as urban density decreased. Tenement reform, indoor plumbing, and the end of multi-family shared sleeping drove disease rates down faster than any pharmaceutical intervention.

Nutrition

Vitamin A deficiency alone multiplies measles mortality. Vitamin C deficiency (scurvy) collapses immune function. As food security improved and industrialization put protein on working-class tables, infection fatality rates fell across every disease — with or without vaccination.

Handwashing & Basic Hygiene

Semmelweis demonstrated in 1847 that handwashing eliminated childbed fever. Germ theory's widespread adoption after 1880 changed medical practice and household habits. Personal hygiene — not vaccination — is the single most evidence-supported infection control measure in history.

Milk Pasteurization & Refrigeration

Raw milk was a primary vector for tuberculosis (bovine TB), scarlet fever, typhoid, and diphtheria. Mandatory pasteurization laws, adopted state-by-state between 1900 and 1950, eliminated an entire transmission route. Refrigeration further cut foodborne illness dramatically.

Medical Management of Complications

Better supportive care — hydration, fever management, treatment of secondary bacterial infections — reduced case fatality rates even without antivirals or vaccines. Children died not from measles virus itself but from bacterial pneumonia and encephalitis that followed dehydration and poor care. Basic nursing changed outcomes.

In a well-nourished child, measles is a self-limiting illness: fever, rash, 7–10 days, full recovery. Before vaccination, 3–4 million Americans got measles every year — and the vast majority recovered without consequence. Vitamin A deficiency is the primary driver of serious complications. The WHO administers Vitamin A to measles patients in deficient populations.

Pre-vaccine era: 3–4 million cases/year, ~400–500 deaths. Today: ~285 cases in a nation of 335 million — 0.000085% of the population. Fatality in otherwise healthy US children: ~1–2 per 1,000 cases, concentrated in immunocompromised and Vitamin A-deficient individuals.

In older children and adults, pertussis is an uncomfortable prolonged cough — the "100-day cough" — that resolves without treatment in the vast majority. Dangerous risk is concentrated in newborns under 3 months, before any immune response has developed. The fear narrative targets all ages equally; the biology does not.

Nearly all pertussis deaths occur in infants under 3 months — before the vaccine schedule even begins. In children over 1 year and adults, pertussis is rarely life-threatening. Approximately 5–10 infant deaths per year in the US.

A routine childhood illness for all of human history. Itchy rash, 5–10 days, lifetime immunity conferred. Serious complications are rare in immunocompetent children. Pre-vaccine, 4 million Americans got chickenpox yearly — and approximately 100 died, mostly in immunocompromised individuals.

The CDC's own economic analysis cited parental work-day loss — not child mortality — as the primary justification for universal varicella vaccination. 100 deaths per year in a population of 260 million (1995) = 0.000038%. Natural infection confers lifetime immunity; varicella vaccination does not, and is linked to a documented rise in shingles rates in adults.

Swollen salivary glands, mild fever, full recovery in 1–2 weeks in the vast majority of children. Natural infection confers lifelong immunity. The feared complication — orchitis (testicular swelling) — occurs in post-pubertal males, not in children, and rarely causes infertility even then.

Pre-vaccine: 186,000 reported cases/year. Now: ~400 in a population of 335 million. Notably, recent mumps outbreaks have occurred predominantly in vaccinated populations — a documented waning immunity problem the CDC has acknowledged.

In children and adults, rubella is almost always mild — rash and low fever lasting 3 days. The only genuine risk is congenital rubella syndrome in a fetus if a pregnant woman is infected in the first trimester. In children, rubella is medically insignificant.

The MMR was designed to protect fetuses by creating population immunity — the risk to children themselves is negligible. Fewer than 10 rubella cases are reported annually in the US. Congenital rubella syndrome now occurs at essentially zero in the US.

Once killed thousands of children annually. Still circulates today — approximately 13,000 cases reported annually in the US. Treated with penicillin, resolving in days. No vaccine was ever developed. No public fear campaign exists. Leprosy circulates at ~200 cases/year — also no campaign. Compare this to measles at 285 cases generating national news coverage.

The pattern is consistent: public fear tracks the available product, not the actual burden of disease. Where there is no vaccine to sell, there is no manufactured emergency.

Annual flu vaccination is recommended for everyone 6 months and older — yet flu vaccine effectiveness is officially estimated at 40–60% in a good year, and sometimes significantly lower (as low as 10% when the predicted strain doesn't match). The CDC acknowledges this annually. Influenza deaths vary dramatically by season: ~12,000 in low years to ~52,000 in severe years — most in adults over 65 and immunocompromised individuals.

Healthy children under 5 have extremely low flu mortality. The primary risk group — elderly and immunocompromised — has the weakest immune response to vaccination. Natural infection with influenza confers broader, more durable immunity than the annual vaccine. The seasonal mismatch problem is structural: the next year's vaccine is manufactured before the circulating strain is known.

COVID-19 vaccines were added to the CDC childhood immunization schedule in 2023. COVID-19 mortality in children under 18 is exceptionally rare — approximately 1,500 total US deaths over the first two years of the pandemic in a population of ~73 million children under 18. The risk to healthy children is comparable to or below seasonal flu.

The VAERS database received more adverse event reports for COVID-19 vaccines in 2021 alone than for all other vaccines combined in all prior years. The myocarditis signal — documented in young males after mRNA vaccination — was confirmed by CDC's own Vaccine Safety Datalink. The risk-benefit calculation for healthy children differs fundamentally from the calculation for older adults.

Hib was a serious cause of bacterial meningitis and epiglottitis in young children. Pre-vaccine, approximately 20,000 cases and 600–1,000 deaths per year. Since the Hib vaccine introduction in 1985–1990, cases dropped to approximately 50/year — one of the clearer examples of vaccination correlating with disease reduction in the target age group.

Hib is one of the stronger cases for vaccine impact. The disease was genuinely dangerous (bacterial meningitis, not a mild illness), the vaccine was introduced before the disease had already declined on its own, and the drop in cases is steep and specific. The honest accounting includes all vaccines — not only the ones that follow the pre-decline pattern.

Wild polio has not circulated in the US since 1979. The oral polio vaccine (OPV) carried a documented risk of vaccine-associated paralytic polio (VAPP) — approximately 1 case per 2.4 million doses. The US switched entirely to inactivated polio vaccine (IPV) in 2000 specifically to eliminate VAPP. The DDT era correlation with polio paralysis peaks remains documented in the literature and underexplored in mainstream narratives.

The US vaccinates against a disease that has not circulated domestically in 45 years. The continued mandate is justified by global circulation risk. Vaccine-derived poliovirus (VDPV) from OPV use abroad has created new outbreaks in Africa and Asia — a complication of the vaccine itself.

Hepatitis B is transmitted through blood-to-blood contact and sexual intercourse. The primary risk group is intravenous drug users, people with multiple sexual partners, and healthcare workers — not newborns in hospital nurseries. A newborn's risk of HepB exposure is essentially zero unless the mother tests positive (which is screened prenatally).

The Hep B vaccine is given on day 1 of life — before the infant leaves the hospital — regardless of maternal HepB status. The justification is that some mothers are positive and don't know it. But the prenatal screen catches this. The vaccine contains aluminum adjuvant. A newborn's immune system, liver, and blood-brain barrier are not fully formed at birth. The risk-benefit calculus for a day-1 vaccine against a sexually transmitted and injection-drug-transmitted disease has never been formally studied against a delay schedule.

Gardasil targets strains of HPV associated with cervical cancer. HPV is one of the most common sexually transmitted infections — most people clear it naturally within 2 years. Cervical cancer in the US causes approximately 4,000 deaths/year, primarily in women who did not receive regular Pap smear screening.

Gardasil has one of the highest VAERS adverse event profiles of any vaccine on the current schedule — including reports of premature ovarian insufficiency, postural orthostatic tachycardia syndrome (POTS), autoimmune conditions, and deaths in adolescent girls. Japan suspended its HPV vaccine recommendation in 2013 after a surge in adverse event reports. The clinical trials used an aluminum-adjuvant placebo (not a saline placebo), making adverse event comparison between groups non-standard. Regular Pap smears remain the evidence-based standard for cervical cancer prevention and detection.